1,2,4-trimethylbenzene increases expression ISO RGD:2546 6480464 pseudocumene results in increased expression of EGR4 protein CTD PMID:17337753 1-naphthyl isothiocyanate decreases expression ISO RGD:2546 6480464 1-Naphthylisothiocyanate results in decreased expression of EGR4 mRNA CTD PMID:12832660 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:2546 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of EGR4 mRNA CTD PMID:26377647 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of EGR4 mRNA CTD PMID:20188158 6-propyl-2-thiouracil decreases expression ISO RGD:2546 6480464 Propylthiouracil results in decreased expression of EGR4 mRNA CTD PMID:24780913 acetylsalicylic acid decreases expression ISO RGD:735817 6480464 Aspirin results in decreased expression of EGR4 mRNA CTD PMID:11906190 aflatoxin B1 decreases methylation ISO RGD:735817 6480464 Aflatoxin B1 results in decreased methylation of EGR4 gene CTD PMID:27153756 ammonium chloride affects expression ISO RGD:2546 6480464 Ammonium Chloride affects the expression of EGR4 mRNA CTD PMID:16483693 aripiprazole increases expression ISO RGD:2546 6480464 Aripiprazole results in increased expression of EGR4 mRNA CTD PMID:17868501 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of EGR4 mRNA CTD PMID:27195522 benzo[a]pyrene increases methylation ISO RGD:735817 6480464 Benzoapyrene results in increased methylation of EGR4 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:735817 6480464 Benzoapyrene affects the methylation of EGR4 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:735817 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:735817 6480464 Diethylhexyl Phthalate results in decreased expression of EGR4 mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA] CTD PMID:27082013 bisphenol A multiple interactions ISO RGD:2546 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of EGR4 mRNA CTD PMID:31129395 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of EGR4 promoter CTD PMID:27334623 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EGR4 mRNA CTD PMID:27082013 butanal increases expression ISO RGD:735817 6480464 butyraldehyde results in increased expression of EGR4 mRNA CTD PMID:26079696 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of EGR4 mRNA CTD PMID:25554681 carbonyl sulfide decreases expression ISO RGD:2546 6480464 carbonyl sulfide results in decreased expression of EGR4 mRNA CTD PMID:19395590 cocaine increases expression ISO RGD:2546 6480464 Cocaine results in increased expression of EGR4 mRNA CTD PMID:27899881 copper(II) sulfate increases expression ISO RGD:735817 6480464 Copper Sulfate results in increased expression of EGR4 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:735817 6480464 Asbestos, Crocidolite results in increased expression of EGR4 mRNA CTD PMID:18687144 cyclophosphamide decreases expression ISO RGD:2546 6480464 Cyclophosphamide results in decreased expression of EGR4 mRNA CTD PMID:27281708 cyclosporin A increases expression ISO RGD:735817 6480464 Cyclosporine results in increased expression of EGR4 mRNA CTD PMID:25562108 cylindrospermopsin increases expression ISO RGD:735817 6480464 cylindrospermopsin results in increased expression of EGR4 mRNA CTD PMID:24921660 decabromodiphenyl ether decreases expression ISO RGD:2546 6480464 decabromobiphenyl ether results in decreased expression of EGR4 mRNA CTD PMID:23640034 disodium selenite decreases expression ISO RGD:735817 6480464 Sodium Selenite results in decreased expression of EGR4 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:735817 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 entinostat multiple interactions ISO RGD:735817 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of EGR4 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:735817 6480464 entinostat results in decreased expression of EGR4 mRNA CTD PMID:26272509 ethanol affects expression EXP 6480464 Ethanol affects the expression of EGR4 mRNA CTD PMID:30319688 fenvalerate increases expression ISO RGD:2546 6480464 fenvalerate results in increased expression of EGR4 mRNA CTD PMID:30307764 fluoxetine decreases expression ISO RGD:2546 6480464 Fluoxetine results in decreased expression of EGR4 mRNA CTD PMID:17033635 glycidol decreases expression ISO RGD:2546 6480464 glycidol results in decreased expression of EGR4 mRNA CTD PMID:24915197 hydrogen peroxide affects expression ISO RGD:735817 6480464 Hydrogen Peroxide affects the expression of EGR4 mRNA CTD PMID:20044591 hydrogen sulfide increases expression EXP 6480464 Hydrogen Sulfide results in increased expression of EGR4 mRNA CTD PMID:31843631 ketamine decreases expression ISO RGD:2546 6480464 Ketamine results in decreased expression of EGR4 mRNA CTD PMID:20080153 lead(0) decreases expression ISO RGD:735817 6480464 Lead results in decreased expression of EGR4 mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:735817 6480464 Lead results in decreased expression of EGR4 mRNA CTD PMID:19921347 leflunomide increases expression ISO RGD:735817 6480464 leflunomide results in increased expression of EGR4 mRNA CTD PMID:28988120 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] affects the expression of EGR4 mRNA CTD PMID:22563483 methamphetamine increases expression ISO RGD:2546 6480464 Methamphetamine results in increased expression of EGR4 mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO RGD:2546 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of EGR4 mRNA CTD PMID:19564919 methotrexate decreases expression ISO RGD:735817 6480464 Methotrexate results in decreased expression of EGR4 mRNA CTD PMID:24449571 methyl methanesulfonate increases expression ISO RGD:735817 6480464 Methyl Methanesulfonate results in increased expression of EGR4 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:735817 6480464 methylmercuric chloride results in increased expression of EGR4 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression ISO RGD:2546 6480464 mono-2-ethylhexylphthalate results in increased expression of EGR4 mRNA CTD PMID:16809437 morphine multiple interactions EXP 6480464 2-2-chloro-4-iodophenylamino-N-cyclopropylmethoxy-3 more ... CTD PMID:22454534 morphine increases expression EXP 6480464 Morphine results in increased expression of EGR4 mRNA CTD PMID:22454534 morphine increases expression ISO RGD:2546 6480464 Morphine results in increased expression of EGR4 mRNA CTD PMID:22454534 morphine multiple interactions ISO RGD:2546 6480464 2-2-chloro-4-iodophenylamino-N-cyclopropylmethoxy-3, 4-difluorobenzamide inhibits the reaction [Morphine results in increased expression of EGR4 mRNA] CTD PMID:22454534 morphine affects response to substance EXP 6480464 EGR4 protein affects the susceptibility to Morphine CTD PMID:22454534 naphthalenes increases expression ISO RGD:2546 6480464 Naphthalenes results in increased expression of EGR4 protein CTD PMID:17337753 p-chloromercuribenzoic acid multiple interactions ISO RGD:735817 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of EGR4 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:735817 6480464 Acetaminophen results in increased expression of EGR4 mRNA CTD PMID:26690555 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] affects the expression of EGR4 mRNA CTD PMID:22563483 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of EGR4 mRNA CTD PMID:22563483 pentanal increases expression ISO RGD:735817 6480464 pentanal results in increased expression of EGR4 mRNA CTD PMID:26079696 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735817 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EGR4 mRNA CTD PMID:16979875 potassium bromate multiple interactions EXP 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA], [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA] CTD PMID:27082013 potassium bromate affects expression EXP 6480464 potassium bromate affects the expression of EGR4 mRNA CTD PMID:27082013 Ptaquiloside increases expression EXP 6480464 ptaquiloside results in increased expression of EGR4 mRNA CTD PMID:23274088 pyridaben decreases expression EXP 6480464 pyridaben results in decreased expression of EGR4 mRNA CTD PMID:22563483 quercetin increases expression ISO RGD:735817 6480464 Quercetin results in increased expression of EGR4 mRNA CTD PMID:21632981 rifampicin multiple interactions ISO RGD:735817 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR4 mRNA CTD PMID:21127053 SB 431542 multiple interactions ISO RGD:735817 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:2546 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of EGR4 mRNA CTD PMID:19564919 SCH 23390 decreases expression ISO RGD:2546 6480464 SCH 23390 results in decreased expression of EGR4 mRNA CTD PMID:19564919 silicon dioxide increases expression ISO RGD:735817 6480464 Silicon Dioxide analog results in increased expression of EGR4 mRNA CTD PMID:23806026 , PMID:25895662 silver atom increases expression ISO RGD:735817 6480464 Silver results in increased expression of EGR4 mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:735817 6480464 Silver results in increased expression of EGR4 mRNA CTD PMID:26551752 Soman increases expression ISO RGD:2546 6480464 Soman results in increased expression of EGR4 mRNA CTD PMID:19281266 tributylstannane multiple interactions ISO RGD:2546 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of EGR4 mRNA CTD PMID:31129395 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of EGR4 mRNA CTD PMID:19042947 undecane increases expression ISO RGD:2546 6480464 undecane results in increased expression of EGR4 protein CTD PMID:17337753 valproic acid increases expression ISO RGD:735817 6480464 Valproic Acid results in increased expression of EGR4 mRNA CTD PMID:24383497 valproic acid decreases expression ISO RGD:2546 6480464 Valproic Acid results in decreased expression of EGR4 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:735817 6480464 Valproic Acid results in decreased expression of EGR4 mRNA CTD PMID:28001369 vinclozolin affects expression ISO RGD:2546 6480464 vinclozolin affects the expression of EGR4 mRNA CTD PMID:19015723 zinc atom multiple interactions ISO RGD:735817 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EGR4 mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO RGD:735817 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EGR4 mRNA CTD PMID:16979875 zoledronic acid increases expression ISO RGD:735817 6480464 zoledronic acid results in increased expression of EGR4 mRNA CTD PMID:20977926